Leap Therapeutics, Inc. (LPTX) Misses Q2 EPS by 5c

Leap Therapeutics, Inc. (NASDAQ: LPTX) reported Q2 EPS of ($0.15), $0.05 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Leap Therapeutics, Inc. (LPTX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital